arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

Annexon, Inc.

ANNX
$3.98 ▼ -0.37 (-8.51%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
31 Visible periods
18 Metrics
Peer-ranked Benchmarks
Price Chart
24
Health
Poor
Bearish
auto_awesome

Analytical Summary

Annexon, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $800.0M
Dividend Yield —
Revenue Growth —
Op. Margin —
ROIC -24.3% ↘
FCF / Share $-0.24 →
Trailing P/E —
Price / Book 4.3x
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

31-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Net Income Profit after all expenses
$-44.14M
↑ +18.8% —
FCF / Share Free cash flow per share
$-0.24
↑ +0.6% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↓
9
Cash Quality ↑
60

Dividend History

Dividend / share · sourced from SEC filings
$0.00 Latest / share

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 8 years · 31 quarters